{
    "root": "3e110564-6fd2-4450-a3d2-a5de70b85f2d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "TOLVAPTAN",
    "value": "20250509",
    "ingredients": [
        {
            "name": "TOLVAPTAN",
            "code": "21G72T1950"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED",
            "code": "2165RE0K14"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 302",
            "code": "91B875MM4H"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "tolvaptan tablets indicated slow kidney function decline adults risk rapidly progressing autosomal dominant polycystic kidney disease ( adpkd ) .",
    "contraindications": "recommended ( 2.1 ) initial titration step target 1 st dose 45 mg 1 st dose 60 mg 1 st dose 90 mg 2 nd dose ( 8 hours later ) 15 mg 2 nd dose ( 8 hours later ) 30 mg 2 nd dose ( 8 hours later ) 30 mg total daily dose 60 mg total daily dose 90 mg total daily dose 120 mg dose adjustment recommended patients taking moderate cyp 3a inhibitors ( 2.4 , 5.4 , 7.1 )",
    "warningsAndPrecautions": "tolvaptan tablets , 15 mg pink light pink coloured , capsule shape , mottled tablets debossed `` f05 `` one side `` lu `` side . tolvaptan tablets , 30 mg pink light pink coloured , round shaped , flat faced bevelled edge mottled tablets debossed `` f06 `` one side `` lu `` side . tolvaptan tablets , 45 mg pink light pink coloured , octagonal shape , mottled tablets debossed `` lu `` one side `` f07 `` side . tolvaptan tablets , 60 mg pink light pink coloured , almond shaped , flat faced bevelled edge mottled tablets debossed `` lu `` one side `` f08 `` side . tolvaptan tablets , 90 mg pink light pink coloured , capsule shaped , biconvex mottled tablets debossed `` lu `` one side `` f09 `` side . tolvaptan tablets supplied : morning afternoon doses ndc 7-day blister card ( containing 14 tablets ) 28-day carton ( 4 blister cards containing total 56 tablets ) 15 mg 15 mg 70748-240-11 70748-240-13 30 mg 15 mg 70748-241-11 70748-241-13 45 mg 15 mg 70748-242-11 70748-242-13 60 mg 30 mg 70748-243-11 70748-243-13 90 mg 30 mg 70748-244-11 70748-244-13 30 count bottles ndc 15 mg 70748-238-06 30 mg 70748-239-06",
    "adverseReactions": "tolvaptan tablets contraindicated patients : history , signs symptoms significant liver impairment injury . contraindication apply uncomplicated polycystic liver disease [ ( 5.1 ) ] taking strong cyp 3a inhibitors uncorrected abnormal blood sodium concentrations [ ( 5.3 ) ] unable sense respond thirst [ ( 5.3 ) ] hypovolemia [ ( 5.3 ) ] hypersensitivity ( e.g . , anaphylaxis , rash ) tolvaptan component product [ ( 6 ) ] uncorrected urinary outflow obstruction anuria",
    "indications_original": "Tolvaptan tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).",
    "contraindications_original": "Recommended dosage ( 2.1 ) Initial Dosage Titration Step Target Dosage 1 st Dose 45 mg 1 st Dose 60 mg 1 st Dose 90 mg 2 nd Dose (8 hours later) 15 mg 2 nd Dose (8 hours later) 30 mg 2 nd Dose (8 hours later) 30 mg Total Daily Dose 60 mg Total Daily Dose 90 mg Total Daily Dose 120 mg Dose adjustment is recommended for patients taking moderate CYP 3A inhibitors ( 2.4 , 5.4 , 7.1 )",
    "warningsAndPrecautions_original": "Tolvaptan tablets, 15 mg are pink to light pink coloured, capsule shape, mottled tablets debossed with \"F05\" on one side and \"LU\" on other side.\n                        Tolvaptan tablets, 30 mg are pink to light pink coloured, round shaped, flat faced bevelled edge mottled tablets debossed with \"F06\" on one side and \"LU\" on other side.\n                        Tolvaptan tablets, 45 mg are pink to light pink coloured, octagonal shape, mottled tablets debossed with \"LU\" on one side and \"F07\" on other side.\n                        Tolvaptan tablets, 60 mg are pink to light pink coloured, almond shaped, flat faced bevelled edge mottled tablets debossed with \"LU\" on one side and \"F08\" on other side.\n                        Tolvaptan tablets, 90 mg are pink to light pink coloured, capsule shaped, biconvex mottled tablets debossed with \"LU\" on one side and \"F09\" on other side.\n                        Tolvaptan tablets are supplied as:\n                        \n                           \n                           \n                           \n                           \n                              \n                                 \n                                     Morning and Afternoon Doses\n                                    \n                                 \n                                 \n                                     NDC\n                                    \n                                 \n                              \n                              \n                                 \n                                     7-Day Blister Card\n                                    \n                                     (Containing 14 Tablets)\n                                    \n                                 \n                                 \n                                     28-Day Carton\n                                    \n                                     (4 Blister Cards Containing a Total of 56 Tablets)\n                                    \n                                 \n                              \n                              \n                                  15 mg and 15 mg\n                                 \n                                  70748-240-11\n                                 \n                                  70748-240-13\n                                 \n                              \n                              \n                                  30 mg and 15 mg\n                                 \n                                  70748-241-11\n                                 \n                                  70748-241-13\n                                 \n                              \n                              \n                                  45 mg and 15 mg\n                                 \n                                  70748-242-11\n                                 \n                                  70748-242-13\n                                 \n                              \n                              \n                                  60 mg and 30 mg\n                                 \n                                  70748-243-11\n                                 \n                                  70748-243-13\n                                 \n                              \n                              \n                                  90 mg and 30 mg\n                                 \n                                  70748-244-11\n                                 \n                                  70748-244-13\n                                 \n                              \n                           \n                        \n                        \n                           \n                           \n                           \n                              \n                                 \n                                     30 Count Bottles\n                                    \n                                 \n                                 \n                                     NDC\n                                    \n                                 \n                              \n                              \n                                  15 mg\n                                 \n                                  70748-238-06\n                                 \n                              \n                              \n                                  30 mg\n                                 \n                                  70748-239-06",
    "adverseReactions_original": "Tolvaptan tablets are contraindicated in patients:\n                  \n                     With a history, signs or symptoms of significant liver impairment or injury. This contraindication does not apply to uncomplicated polycystic liver disease [see Warnings and Precautions (5.1)]\n                     \n                     Taking strong CYP 3A inhibitors\n                     With uncorrected abnormal blood sodium concentrations [see Warnings and Precautions (5.3)]\n                     \n                     Unable to sense or respond to thirst [see Warnings and Precautions (5.3)]\n                     \n                     Hypovolemia [see Warnings and Precautions (5.3)]\n                     \n                     Hypersensitivity (e.g., anaphylaxis, rash) to tolvaptan or any component of the product [see Adverse Reactions (6)]\n                     \n                     Uncorrected urinary outflow obstruction\n                     Anuria"
}